Australia markets closed

JW Pharmaceutical Corporation (001067.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
59,000.00-300.00 (-0.51%)
At close: 03:30PM KST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
15,908,868
33,897,925
33,366,477
10,451,341
Other short-term investments
78,287,564
115,780,503
32,299,584
44,839,817
Total cash
94,196,432
149,678,428
65,666,061
55,291,158
Net receivables
159,377,671
147,522,570
151,779,742
122,833,091
Inventory
106,091,354
111,668,427
102,527,604
101,197,789
Other current assets
2,189,724
1,963,722
5,417,831
10,096,267
Total current assets
378,091,350
425,457,064
366,451,501
299,328,713
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
340,590,927
302,304,228
286,739,067
360,549,520
Accumulated depreciation
-184,867,257
-179,256,113
-168,346,798
-174,977,801
Net property, plant and equipment
155,723,670
123,048,115
118,392,269
185,571,718
Goodwill
1,404,470
-
-
-
Intangible assets
28,951,954
16,266,195
21,473,082
17,666,148
Other long-term assets
-0.02
0.02
-0.64
-0.02
Total non-current assets
266,947,446
202,515,691
266,601,635
249,756,316
Total assets
645,038,796
627,972,755
633,053,136
549,085,029
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
113,134,174
206,439,728
121,800,182
106,466,176
Accounts payable
73,847,213
82,907,880
51,642,851
47,885,391
Other current liabilities
12,899,977
22,231,766
35,045,577
42,299,852
Total current liabilities
286,927,114
380,131,098
282,677,564
234,747,629
Non-current liabilities
Long-term debt
30,000,000
-
120,743,640
73,584,994
Deferred tax liabilities
1,276,101
1,399,225
-
-
Deferred revenues
8,839
-
-
-
Other long-term liabilities
1,316,566
0.49
-0.16
0.55
Total non-current liabilities
92,671,226
22,082,621
161,836,043
106,870,525
Total liabilities
379,598,339
402,213,719
444,513,607
341,618,154
Stockholders' equity
Common stock
61,099,530
59,418,178
57,202,368
55,615,810
Retained earnings
113,029,398
89,129,836
58,594,736
65,083,851
Total stockholders' equity
265,440,456
240,354,100
201,194,767
207,490,914
Total liabilities and stockholders' equity
645,038,796
627,972,755
633,053,136
549,085,029